Landmark gene-editing therapy approved: here’s what you need to know
The FDA approved the landmark treatment on Friday. It’s expected to cost more than $1 million.
Today's Liberal News
By Lauren Gardner and Katherine Ellen Foley
Landmark gene-editing therapy approved: here’s what you need to know
The FDA approved the landmark treatment on Friday. It’s expected to cost more than $1 million.
Landmark gene-editing therapy approved: here’s what you need to know
The FDA approved the landmark treatment on Friday. It’s expected to cost more than $1 million.
Landmark gene-editing therapy approved: here’s what you need to know
The FDA approved the landmark treatment on Friday. It’s expected to cost more than $1 million.
Landmark gene-editing therapy approved: here’s what you need to know
The FDA approved the landmark treatment on Friday. It’s expected to cost more than $1 million.
Landmark gene-editing therapy approved: here’s what you need to know
The FDA approved the landmark treatment on Friday. It’s expected to cost more than $1 million.
FDA authorizes Pfizer, Moderna Covid-19 vaccines for babies, toddlers
Now the CDC’s vaccine expert panel will review for recommendation to the CDC director.
FDA authorizes Pfizer, Moderna Covid-19 vaccines for babies, toddlers
Now the CDC’s vaccine expert panel will review for recommendation to the CDC director.
FDA authorizes Pfizer, Moderna Covid-19 vaccines for babies, toddlers
Now the CDC’s vaccine expert panel will review for recommendation to the CDC director.
FDA authorizes Pfizer, Moderna Covid-19 vaccines for babies, toddlers
Now the CDC’s vaccine expert panel will review for recommendation to the CDC director.
FDA authorizes Pfizer, Moderna Covid-19 vaccines for babies, toddlers
Now the CDC’s vaccine expert panel will review for recommendation to the CDC director.
FDA authorizes Pfizer, Moderna Covid-19 vaccines for babies, toddlers
Now the CDC’s vaccine expert panel will review for recommendation to the CDC director.
FDA advisers vote to recommend Novavax Covid-19 vaccine
Advisers signaled interest in making available a vaccine made with a technology different from the messenger RNA shots that have dominated the U.S. immunization arsenal against the disease.
FDA advisers vote to recommend Novavax Covid-19 vaccine
Advisers signaled interest in making available a vaccine made with a technology different from the messenger RNA shots that have dominated the U.S. immunization arsenal against the disease.
FDA advisers vote to recommend Novavax Covid-19 vaccine
Advisers signaled interest in making available a vaccine made with a technology different from the messenger RNA shots that have dominated the U.S. immunization arsenal against the disease.
FDA advisers vote to recommend Novavax Covid-19 vaccine
Advisers signaled interest in making available a vaccine made with a technology different from the messenger RNA shots that have dominated the U.S. immunization arsenal against the disease.
CDC recommends Pfizer-BioNTech Covid-19 booster for kids 5-11
The committee found that the vaccine has largely been safe for that population of children, with incidents of myocarditis and other rare adverse events lower compared to older kids.
CDC recommends Pfizer-BioNTech Covid-19 booster for kids 5-11
The committee found that the vaccine has largely been safe for that population of children, with incidents of myocarditis and other rare adverse events lower compared to older kids.
CDC recommends Pfizer-BioNTech Covid-19 booster for kids 5-11
The committee found that the vaccine has largely been safe for that population of children, with incidents of myocarditis and other rare adverse events lower compared to older kids.
CDC recommends Pfizer-BioNTech Covid-19 booster for kids 5-11
The committee found that the vaccine has largely been safe for that population of children, with incidents of myocarditis and other rare adverse events lower compared to older kids.
Novavax asks FDA to authorize its Covid shot
The company is aiming to produce at least 2 billion doses of its vaccine in 2022, of which the U.S. has ordered 100 million.
Novavax asks FDA to authorize its Covid shot
The company is aiming to produce at least 2 billion doses of its vaccine in 2022, of which the U.S. has ordered 100 million.
Novavax asks FDA to authorize its Covid shot
The company is aiming to produce at least 2 billion doses of its vaccine in 2022, of which the U.S. has ordered 100 million.
Omicron complicates puzzle over at-home Covid pill
Independent advisers to the FDA endorsed the pill, molnupiravir, in an unusually tight 13-10 vote this week after airing concerns about its low efficacy rate and potential safety risks to pregnant people.
Omicron complicates puzzle over at-home Covid pill
Independent advisers to the FDA endorsed the pill, molnupiravir, in an unusually tight 13-10 vote this week after airing concerns about its low efficacy rate and potential safety risks to pregnant people.
Omicron complicates puzzle over at-home Covid pill
Independent advisers to the FDA endorsed the pill, molnupiravir, in an unusually tight 13-10 vote this week after airing concerns about its low efficacy rate and potential safety risks to pregnant people.
FDA authorizes first Covid vaccine for kids ages 5-11
The CDC’s vaccine advisers are scheduled to meet Tuesday to evaluate the shot, and are expected to vote in favor of its use
FDA authorizes first Covid vaccine for kids ages 5-11
The CDC’s vaccine advisers are scheduled to meet Tuesday to evaluate the shot, and are expected to vote in favor of its use
FDA authorizes first Covid vaccine for kids ages 5-11
The CDC’s vaccine advisers are scheduled to meet Tuesday to evaluate the shot, and are expected to vote in favor of its use
FDA authorizes first Covid vaccine for kids ages 5-11
The CDC’s vaccine advisers are scheduled to meet Tuesday to evaluate the shot, and are expected to vote in favor of its use